Cardiovascular Disease Risk of Awareness

Necmettin Erbakan University

Status: Not yet enrolling

Conditions: Cardiovascular Diseases

Treatments: Other: Monitoring; Other: Training and Consultancy; Other: Mobile Application; Other: Cardiovascular disease risk assessment

Study type: Interventional

Funder types: Other

Identifiers

NCT06000436

NecmettinEU70

Details and patient eligibility

About

The Cardiovascular Risk Reduction Program (CARDIOREP) aims to raise risk awareness and reduce risk factors.

Full description

While 1/3 of premature deaths in individuals under the age of 70 in the world occur due to Cardiovascular Diseases (WHO 2022), circulatory system diseases are at the forefront with 36.76% according to the health statistics of the Ministry of Health in our country. It is necessary to raise awareness and gain healthy lifestyle behaviors in the prevention of cardiovascular diseases. The Cardiovascular Risk Reduction Program (CARDIOREP) aims to raise risk awareness and reduce risk factors.

Enrollment: 54 estimated patients

Sex: All

Ages: 40+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Not having been diagnosed with cardiovascular disease.
• Using a smartphone.
• Agree to use the Google Fit App.

Exclusion Criteria:

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

54 participants in 2 patient groups

Intervention/treatment

Experimental group

Description:

Health education, mobile applications, monitoring, Cardiovascular disease risk assessment

Treatment:

Other: Cardiovascular disease risk assessment

Other: Mobile Application

Other: Monitoring

Other: Training and Consultancy

Active group

Active Comparator group

Description:

Cardiovascular disease risk assessment

Treatment:

Other: Cardiovascular disease risk assessment

Other: Monitoring